Prohost Biotech - Exclusive Biotech Research ~ A Comprehensive Resource for Biotech News

Moderna Therapeutics: A Big Day Filled with Good News

September 13, 2019 0

Moderna Therapeutics Trial Results Moderna Therapeutics (MRNA) trial results mark the first systemic mRNA therapeutic to show the production of a secreted protein in humans. Moderna’s Product mRNA-1944 successfully encoded for functional antibody (CHKV-24) in humans at all dose levels tested (0.1, 0.3 and 0.6 mg/kg). The antibody level reached is predicted to protect against chikungunya infection achieved within hours. …

Outperforming Biotechs In a Bad Market Day

Amgen to Acquire Celgene’s Product Otezla at $13.4 Billion

AstraZeneca and Vertex Both Have Good News

Why Akari Therapeutics Stock Price Rallied Today

Why Amgen’s Stock Is Up Over $11 Today

Rhythm Pharmaceuticals Has Good News. See Also: The Novartis News...

RegenxBio Has Good News

Halozyme and argenx Most Recent News

The Gilead and Galapagos Agreement Is a Big Win for...

Regeneron’s Product Libtayo is Unique and Expected to Become a...

Gilead to File NDA for Rheumatoid Arthritis Drug Filgotinib. Karyopharm...

ImmunoGen: Experiencing Big Internal Changes

The FDA Approved AMAG Pharmaceuticals’ Product Vyleesi™ for Premenopausal Women...

Pfizer to Acquire Array Biopharma at $48 a Share

bluebird bio: Why This Firm’s Stock Gained $6.37 Yesterday

Novartis: Psoriatic Arthritis Patients on Cosentyx Had No Radiologic Progression...

bluebird bio Announces a European Conditional Approval of Its Gene...

Cara Therapeutics: More Positive Results from the Korsuva Product Trial...

Vertex: Good News and Good Decisions

Today’s Highlights

About RegenxBio’s Agreement with Clearside Biomedical and More

September 10, 2019 0

Diseases of the Back of the Eye Diseases of the back of the eye, such as: age-related …

Amgen’s Oncology Product AMG-510 Meeting An Unmet Need for Kras G12C Mutated Cancers

September 9, 2019 0

Amgen's Outperforming After being boxed in, for the past couple of weeks, Amgen’s (AMGN) stock finally outperformed. …

Vertex: In Pursuit of Cures

September 4, 2019 0

Vertex Pharmaceuticals Is Acquiring Semma Therapeutics Vertex Pharmaceutical (VRTX) entered into a definitive agreement to buy a …

Gene Therapy and Other Treatments That Work at the Genetic Level

August 30, 2019 0

Gene Therapy Stocks Experiencing Selloffs Every investor in the biotech sector must have experienced selloffs of …

The Medicines Company Has Agreeable News

August 27, 2019 0

The Medicines Company The Medicines Company (MDCO) focuses on cardiovascular diseases. Major goals are halting the …

Regeneron: Successful Cure for Ebola-Infected People. Read Also: The Midday Outperforming Biotech Stocks

August 13, 2019 0

Regeneron Product REGN-EB3 Saving Lives Regeneron (REGN) announced that an independent monitoring board ended its investigational product …

Nektar’s Story Has Nothing to Do with the Efficacy Or the Value of NKTR-214

August 9, 2019 2

Nektar Therapeutics Story Everything was going well with Nektar Therapeutics (NKTR) stock during the Conference call …

Unveiled Good News About Prohost Picked Biotech Stocks

August 8, 2019 0

The News Prohost Was Waiting for to Post Its Special Letter Prohost has one eye on …

What We Learned from Yesterday’s and Today’s Stocks’ Moves

August 6, 2019 0

What Have We Learned from the Market's Recent Stock Moves? Well. Did we learn anything from …

An Important Statement to Prohost Readers

August 5, 2019 0

Prohost has just finished a very hard task; evaluating its best picks from the biotechnology and …

The Week in Review

The Bizarre Market

August 20, 2019 0

The Week in Review #41 We Are Still Witnessing … The bizarre market performance that started …

The Week in Review #40

April 16, 2019 0

Conquering NASH Gilead and Novo Nordisk Conquering NASH What was Gilead Sciences' (GILD) announcement at …

During the Departed Week

March 19, 2019 0

The Week in Review #39 During the Departed Week Three Prohost Portfolio Picks Hit Their 52-Week …

Good news and setbacks during the departed week

March 5, 2019 0

The Week in Review #38 SYNOPSIS Good News and Setbacks During the Departed Week from the …

The Week in Review #37

February 19, 2019 0

From the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) Prostate Cancer A presentation …

Now You See It, Now You Don’t

January 28, 2019 0

Now You See it, Now You Don’t Deliberate Omissions of Real Facts Real facts might be …

Politics and the Market

December 11, 2018 0

The Week in Review #35 Politics and the Market The market tumbled today as Theresa May, …

Improving on immunotherapy and preventing one of its serious side effects

November 13, 2018 0

The Week in Review #34 Improving on Immunotherapy and preventing one of its serious side effects. …

We call it the bad market

October 30, 2018 0

The Week in Review #33 WE CALL IT THE BAD MARKET The Federal Reserve’s raising of …

Positive News

October 22, 2018 0

The Week in Review #32 POSITIVE NEWS PROTEOSTASIS THERAPEUTICS Cystic Fibrosis Two days ago, a clinical-stage …

Prohost Letters

The Value of the Biotech Companies

August 12, 2019 0

Prohost Letter #434 Special Issue The Value of the Biotech Companies With a strong economy and …

Treating Hemoglobinopathies

June 21, 2019 0

Prohost Letter #433 Treating Hemoglobinopathies The most common genetic blood disorders are the hemoglobinopathies: sickle cell …

The ASCO 2019 Special Edition

June 11, 2019 0

Prohost Letter #432 The ASCO 2019 Special Edition SPRAYING FEAR The Victims Are The most disturbed …

Genomes, Genes and Gene Therapies

May 28, 2019 0

Prohost Letter #431 Genomes, Genes and Gene Therapies In this issue of the Prohost Letter we …

Prohost Letter #430

April 5, 2019 0

Prohost Letter #430 Rheumatoid Arthritis and Gilead The FINCH 1 trial: Has it reached its primary …

End of the Year Decisions ~ Part 4

March 14, 2019 0

Prohost Letter #429 End of the Year Decisions ~ Part 4 We picked for our portfolio …

End of the Year Decisions ~ Part 3

February 10, 2019 0

Prohost Letter #428 End of the Year Decisions ~ Part 3 In Part 3 of this …

End of the Year Decisions Part 2

January 24, 2019 0

Prohost Letter #427 End of the Year Decisions ~ Part 2 As a result of the unexpected …

End of the Year Decisions ~ Part 1

January 15, 2019 1

Prohost Letter #426 End of the Year Decisions ~ Part 1 We decided to make this …

The NEW Prohost Portfolio for 2019

January 3, 2019 0

The NEW Prohost Portfolio Small Important Changes We are making some very small but important changes …